Evidence map›Paper›PMID 41393209›Full record

ArticleRSC advances2025

Synthesis, photochemical and biological evaluation of novel photoswitchable glycomimetic ligands of

Shapla Bhattacharya, Giorgia Tempra, Alessio Colleoni, Carlo Matera, Rossella Castagna, Emilio Parisini

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shapla BhattacharyaDepartment of Biotechnology, Latvian Institute of Organic Synthesis Aizkraukles 21 LV-1006 Riga Latvia emilio.parisini@osi.lv.ORCID https://orcid.org/0000-0002-1286-5138
Giorgia TempraDepartment of Pharmaceutical Sciences, University of Milan Via Luigi Mangiagalli 25 20133 Milan Italy.ORCID https://orcid.org/0009-0001-3438-2436
Alessio ColleoniDepartment of Pharmaceutical Sciences, University of Milan Via Luigi Mangiagalli 25 20133 Milan Italy.ORCID https://orcid.org/0009-0003-7493-1553
Carlo MateraDepartment of Pharmaceutical Sciences, University of Milan Via Luigi Mangiagalli 25 20133 Milan Italy.ORCID https://orcid.org/0000-0001-6939-3859
Rossella CastagnaDepartment of Biotechnology, Latvian Institute of Organic Synthesis Aizkraukles 21 LV-1006 Riga Latvia emilio.parisini@osi.lv.ORCID https://orcid.org/0000-0002-9284-3165
Emilio ParisiniDepartment of Biotechnology, Latvian Institute of Organic Synthesis Aizkraukles 21 LV-1006 Riga Latvia emilio.parisini@osi.lv.ORCID https://orcid.org/0000-0002-5529-0039

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial multidrug resistance (MDR) poses a major threat to global health. The continued use of antibiotics, combined with genetic variations and exposure to nosocomial infections, has led to the selection and spread of multidrug-resistant bacteria. In recent years, photopharmacology has emerged as a strategy to combat MDR by enabling precise, light-controlled spatiotemporal modulation of the biological activity of photo-switchable compounds. Among different microbial species,

Identifiers

PMID41393209
PMCPMC12700220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.